In a major leap for regenerative medicine, Sheba Medical Centre in Israel, working with Tel Aviv University, has successfully developed lab-grown 3D kidney organoids that survived for more than 34 weeks — a record in the field.
Why This Matters
Until now, kidney organoids (miniature, lab-grown versions of kidneys) struggled to survive beyond four weeks, severely limiting their usefulness. The new development marks a turning point in:
- Kidney disease research – Organoids allow scientists to model kidney disorders and understand their underlying mechanisms.
- Drug testing – These lab-grown kidneys could reduce reliance on animal models, speeding up safer drug development.
- Future therapies – Instead of direct cell transplantation, the biomolecules secreted by organoids may help repair injured kidneys naturally.
The Bigger Picture
Dr. Benjamin Dekel, head of Sheba’s Pediatric Nephrology Unit and Stem Cell Research Institute, said he was “very, very optimistic about the path forward.” According to him, the long-lived organoids don’t just mimic kidney function but also secrete molecules that could one day be harnessed for healing damaged human kidneys.
Clinical Applications Still Far Off
While promising, scientists caution that translating this research into real-world treatments will take time. Key challenges include:
- Identifying the most effective cells to use.
- Understanding precisely how the biomolecules aid repair.
- Ensuring safety and scalability for human use.
Still, the achievement is being hailed as a historic milestone that could transform the way kidney disease is studied and treated in the future.
Image Source: Google | Image Credit: Respective Owner
